Presentation TCT 2017 Sirolimus Angioplasty Balloon for In-Stent Restenosis (SABRE) Trial: 2-Year Clinical Follow-Up Presenter: Emmanouil S. Brilakis, Christopher E. Buller, Pieter R. Stella November 01, 2017
Presentation TCT 2017 TCT 571: Different Tissue Morphology of In-stent Restenosis in Hemodialysis Patient Compared With Non-hemodialysis Patients: A Prospective Multicenter Optical Coherence Tomography Registry Presenter: Francesco Prati, Renu Virmani, Yoshinori Nagasawa, MD October 31, 2017
Presentation TCT 2017 RIBS IV: 3-Year Outcomes From a Randomized Trial of a Metallic DES vs a Drug-Eluting Balloon in Patients With DES Restenosis Presenter: Thomas F. Luscher, Fernando Alfonso October 31, 2017
Presentation TCT 2017 Management of External Iliac Artery In-stent Restenosis Presenter: Ehrin J. Armstrong, Brian G. DeRubertis October 31, 2017
Presentation TCT 2017 DCB Preclinical Perspectives: Mechanisms and Experimental Safety and Efficacy of Older, Current, and Futuristic DCB Presenter: Robert A. Byrne, Ran Kornowski, Juan F. Granada October 30, 2017
Presentation TCT 2017 Treatment of Refractory In-Stent Restenosis State-of-the-Art Review: From Standard Approaches to Parental Drugs and Vascular Brachytherapy Presenter: Robert A. Byrne, Ran Kornowski, Ron Waksman October 30, 2017
Presentation TCT 2017 Treatment of First-time In-Stent Restenosis State-of-the-Art Review: From Lesion Preparation and Imaging to Restenting to DCB Presenter: Robert A. Byrne, Ran Kornowski, Fernando Alfonso October 30, 2017
Presentation TCT 2017 Does DCB Technology Have an Important Role in Treatment of De Novo Coronary Artery Disease? If Not Today, Tomorrow? Presenter: Robert A. Byrne, Ran Kornowski, Bernardo Cortese October 30, 2017
Presentation TCT 2017 Drug-Coated Coronary Balloon Therapy: Current State-of-the-Art Presenter: Robert A. Byrne, Ran Kornowski, Bruno Scheller October 30, 2017
Presentation TCT 2017 Tradeoffs of Embolic Protection and Sealing vs Restenosis: Utility of the Micronet MGuard Stent for MI, SVG, Aneurysms, and More Presenter: Julinda Mehilli, Giulio G. Stefanini, Dariusz Dudek October 30, 2017
Presentation TCT 2017 DARE: A Randomized Trial of a Drug-Eluting Balloon vs a Metallic DES in Patients With Coronary Artery In-Stent Restenosis Presenter: Fernando Alfonso, Jose P.S. Henriques October 30, 2017
Presentation TCT 2017 Drug-Eluting Stent Thrombosis and Restenosis: Mechanisms, Frequency, and Treatment Presenter: Joseph P. Carrozza Jr, Jose M. Wiley, Binita Shah October 29, 2017
Presentation Incidence, Procedural Management, and Clinical Outcomes of Coronary In-stent Restenosis July 19, 2017
Presentation Fellows 2017 Stent Thrombosis and Restenosis Presenter: Emmanouil S. Brilakis, Ajay J. Kirtane April 08, 2017
Presentation Beyond Restenosis: Patients’ Preference for Drug-Eluting or Bare-Metal Stents February 13, 2017
Presentation TCT 2016 RIBS VI: A Prospective, Multicenter Registry of Bioresorbable Vascular Scaffolds in Patients With Coronary Artery Bare Metal or Drug-Eluting In-Stent Restenosis Six Month-Nine Month Clinical and Angiographic Follow-up Results Presenter: Gary S. Mintz, Robert-Jan van Geuns, Fernando Alfonso November 02, 2016
Presentation TCT 2016 How to Treat BRS Restenosis (With Case Examples) Presenter: Ashok Seth, Pieter C. Smits November 01, 2016
Presentation TCT 2016 DEBATE: DCB for In-Stent Restenosis: Does the Current Data Support Broad Adoption? Yes! The Data is Solid and DCB Should be the Treatment of Choice! Presenter: Fernando Alfonso, Juan F. Granada, Bruno Scheller November 01, 2016